224 related articles for article (PubMed ID: 30716449)
1. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
Sun Q; Zhang B; Zhu W; Wei W; Ma J; Tay FR
J Dent; 2019 Mar; 82():91-97. PubMed ID: 30716449
[TBL] [Abstract][Full Text] [Related]
2. miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene.
Mao Y; Chen Y; Fu Y; Guan J; Liang M; Zhu Y; Yang F; Li F; Zhang Z; Wan C; Zhou P
In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):533-542. PubMed ID: 32839904
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-455-3p regulates proliferation and osteoclast differentiation of RAW264.7 cells by targeting PTEN.
Zhang X; Wang L; Huang N; Zheng Y; Cai L; Ke Q; Wu S
BMC Musculoskelet Disord; 2022 Apr; 23(1):340. PubMed ID: 35397519
[TBL] [Abstract][Full Text] [Related]
4. MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B.
Sun L; Lian JX; Meng S
Cell Mol Biol Lett; 2019; 24():23. PubMed ID: 30976285
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-548-3p overexpression inhibits proliferation, migration and invasion in osteoblast-like cells by targeting STAT1 and MAFB.
Ramírez-Salazar EG; Almeraya EV; López-Perez TV; Patiño N; Salmeron J; Velázquez-Cruz R
J Biochem; 2020 Sep; 168(3):203-211. PubMed ID: 32196088
[TBL] [Abstract][Full Text] [Related]
6. miR-338-3p regulates osteoclastogenesis via targeting IKKβ gene.
Niu D; Gong Z; Sun X; Yuan J; Zheng T; Wang X; Fan X; Mao Y; Liu X; Tang B; Fu Y
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):243-251. PubMed ID: 30887211
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA KCNQ1OT1 inhibits osteoclast differentiation by regulating the miR-128-3p/NFAT5 axis.
Zhang H; Chen L; Wang Z; Sun Z; Shan Y; Li Q; Qi L; Wang H; Chen Y
Aging (Albany NY); 2022 May; 14(10):4486-4499. PubMed ID: 35587369
[TBL] [Abstract][Full Text] [Related]
8. The function of miR-218 and miR-618 in postmenopausal osteoporosis.
Wang WW; Yang L; Wu J; Gao C; Zhu YX; Zhang D; Zhang HX
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5534-5541. PubMed ID: 29271983
[TBL] [Abstract][Full Text] [Related]
9. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
[TBL] [Abstract][Full Text] [Related]
11. MiR-221-5p/Smad3 axis in osteoclastogenesis and its function: Potential therapeutic target for osteoporosis.
Guo M; Liu N; Guo Z
Steroids; 2022 Sep; 185():109063. PubMed ID: 35700796
[TBL] [Abstract][Full Text] [Related]
12. MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2.
Hu L; Xie X; Xue H; Wang T; Panayi AC; Lin Z; Xiong Y; Cao F; Yan C; Chen L; Cheng P; Zha K; Sun Y; Liu G; Yu C; Hu Y; Tao R; Zhou W; Mi B; Liu G
Exp Mol Med; 2022 Jul; 54(7):961-972. PubMed ID: 35831436
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
14. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
Li M; Luo R; Yang W; Zhou Z; Li C
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
[TBL] [Abstract][Full Text] [Related]
15. ATF1/miR-214-5p/ITGA7 axis promotes osteoclastogenesis to alter OVX-induced bone absorption.
Liu LL; Xiao YS; Huang WM; Liu S; Huang LX; Zhong JH; Jia P; Liu WY
Mol Med; 2022 May; 28(1):56. PubMed ID: 35568813
[TBL] [Abstract][Full Text] [Related]
16. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y
Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-133a is involved in the regulation of postmenopausal osteoporosis through promoting osteoclast differentiation.
Li Z; Zhang W; Huang Y
Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):273-280. PubMed ID: 29425279
[TBL] [Abstract][Full Text] [Related]
18. A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3).
Liu T; Qin AP; Liao B; Shao HG; Guo LJ; Xie GQ; Yang L; Jiang TJ
Bone; 2014 Oct; 67():156-65. PubMed ID: 25019593
[TBL] [Abstract][Full Text] [Related]
19. Pathway analysis of microRNA expression profile during murine osteoclastogenesis.
Franceschetti T; Dole NS; Kessler CB; Lee SK; Delany AM
PLoS One; 2014; 9(9):e107262. PubMed ID: 25222202
[TBL] [Abstract][Full Text] [Related]
20. MiR-142-3p is a RANKL-dependent inducer of cell death in osteoclasts.
Fordham JB; Guilfoyle K; Naqvi AR; Nares S
Sci Rep; 2016 Apr; 6():24980. PubMed ID: 27113904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
